FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

10685111000001105: Nexavar 200mg tablets (Bayer Plc) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Apr 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
36904001000001116 Nexavar 200mg tablets (Bayer Plc) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
36904101000001115 Nexavar 200mg tablets (Bayer Plc) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Nexavar 200mg tablets (Bayer Plc) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Nexavar 200mg tablets (Bayer Plc) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Nexavar 200mg tablets (Bayer Plc) Is a Product containing precisely sorafenib (as sorafenib tosylate) 200 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Nexavar 200mg tablets (Bayer Plc) Has active ingredient Sorafenib tosylate false Inferred relationship Existential restriction modifier
Nexavar 200mg tablets (Bayer Plc) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Nexavar 200mg tablets (Bayer Plc) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Nexavar 200mg tablets (Bayer Plc) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Nexavar 200mg tablets (Bayer Plc) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Nexavar 200mg tablets (Bayer Plc) Is a Nexavar true Inferred relationship Existential restriction modifier
Nexavar 200mg tablets (Bayer Plc) Has active ingredient Sorafenib tosylate false Inferred relationship Existential restriction modifier
Nexavar 200mg tablets (Bayer Plc) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Sorafenib true Inferred relationship Existential restriction modifier
Nexavar 200mg tablets (Bayer Plc) Has specific active ingredient Sorafenib tosylate true Inferred relationship Existential restriction modifier
Nexavar 200mg tablets (Bayer Plc) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Nexavar 200mg tablets (Bayer Plc) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Nexavar 200mg tablets (Bayer Plc) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Nexavar 200mg tablets (Bayer Plc) Has basis of strength substance Sorafenib true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Nexavar 200mg tablets (Bayer Plc) 112 tablet 4 x 28 tablets Is pack of False Nexavar 200mg tablets (Bayer Plc) Inferred relationship Existential restriction modifier
Nexavar 200mg tablets (Bayer Plc) 112 tablet 4 x 28 tablets Has AMP True Nexavar 200mg tablets (Bayer Plc) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start